These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 21738254
1. Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease. García Agudo R, Aoufi Rabih S, Pérez Roldán F, Guzmán Ames F, González Carro P, Ruiz Carrillo F, Cuesta Domínguez R. Nefrologia; 2011; 31(4):490-2. PubMed ID: 21738254 [No Abstract] [Full Text] [Related]
2. The transjugular route: the key hole to the liver world. Senzolo M, Burra P, Cholongitas E, Lodato F, Marelli L, Manousou P, Patch D, Sturniolo GC, Burroughs AK. Dig Liver Dis; 2007 Feb; 39(2):105-16. PubMed ID: 17196894 [Abstract] [Full Text] [Related]
4. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation. Carrión JA, Fernández-Varo G, Bruguera M, García-Pagán JC, García-Valdecasas JC, Pérez-Del-Pulgar S, Forns X, Jiménez W, Navasa M. Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026 [Abstract] [Full Text] [Related]
5. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis. Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, Mela M, Manousou P, Senzolo M, Dhillon AP, Patch D, Burroughs AK. Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383 [Abstract] [Full Text] [Related]
6. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, Grando-Lemaire V, Trinchet JC, Beaugrand M. Aliment Pharmacol Ther; 2008 Nov 01; 28(9):1102-10. PubMed ID: 18691352 [Abstract] [Full Text] [Related]
7. Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection. Becker VR, Badiani RG, Lemos LB, Perez RM, Medina-Pestana JO, Lanzoni VP, Ferreira AP, Silva AE, Ferraz ML. Eur J Gastroenterol Hepatol; 2009 Dec 01; 21(12):1395-9. PubMed ID: 19525852 [Abstract] [Full Text] [Related]
8. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Blasco A, Forns X, Carrión JA, García-Pagán JC, Gilabert R, Rimola A, Miquel R, Bruguera M, García-Valdecasas JC, Bosch J, Navasa M. Hepatology; 2006 Mar 01; 43(3):492-9. PubMed ID: 16496308 [Abstract] [Full Text] [Related]
9. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Liver Transpl; 2006 Dec 01; 12(12):1791-8. PubMed ID: 16823833 [Abstract] [Full Text] [Related]
10. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Thalheimer U, Bellis L, Puoti C, Burroughs AK. Eur J Intern Med; 2011 Feb 01; 22(1):5-7. PubMed ID: 21238884 [Abstract] [Full Text] [Related]
11. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Perelló A, Escorsell A, Bru C, Gilabert R, Moitinho E, García-Pagán JC, Bosch J. Hepatology; 1999 Dec 01; 30(6):1393-7. PubMed ID: 10573517 [Abstract] [Full Text] [Related]
12. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group. Gastroenterology; 2007 Aug 01; 133(2):481-8. PubMed ID: 17681169 [Abstract] [Full Text] [Related]
13. Combined liver and kidney transplantation. Papafragkakis H, Martin P, Akalin E. Curr Opin Organ Transplant; 2010 Jun 01; 15(3):263-8. PubMed ID: 20386445 [Abstract] [Full Text] [Related]
15. Management of HCV infection in chronic kidney disease. Aoufi Rabih S, García Agudo R. Nefrologia; 2011 May 01; 31(3):260-7. PubMed ID: 21407274 [Abstract] [Full Text] [Related]
16. Hepatic venous pressure gradient supplements liver biopsy in the diagnosis of cirrhosis. Wolf AT, Maurer R, Glickman J, Grace ND. J Clin Gastroenterol; 2008 Feb 01; 42(2):199-203. PubMed ID: 18209592 [Abstract] [Full Text] [Related]
17. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities. Jouët P, Meyrier A, Mal F, Callard P, Guettier C, Stordeur D, Trinchet JC, Beaugrand M. Hepatology; 1996 Nov 01; 24(5):1143-7. PubMed ID: 8903389 [Abstract] [Full Text] [Related]
18. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME. N Engl J Med; 1969 Jun 19; 280(25):1367-71. PubMed ID: 4890476 [No Abstract] [Full Text] [Related]
19. Hepatitis C, HCV genotypes and hepatic siderosis in patients with chronic renal failure on haemodialysis in Brazil. de Paula Farah K, Carmo RA, de Figueiredo Antunes CM, Serufo JC, Nobre Júnior VA, Fonseca de Castro LP, Leite VH, Silva RA, Alvares MC, Corrêa GO, Busek SC, Lambertucci JR. Nephrol Dial Transplant; 2007 Jul 19; 22(7):2027-31. PubMed ID: 17309883 [Abstract] [Full Text] [Related]
20. Steatosis and portal hypertension. Puoti C, Bellis L. Eur Rev Med Pharmacol Sci; 2005 Jul 19; 9(5):285-90. PubMed ID: 16231591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]